Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease
by
Globally recognized biotechnology innovator and distributor, Bharat Biotech, along with CMR, has announced promising Phase 3 trial Interim Results for COVAXIN®. Analysis based on a study that enrolled 25,800 participants between the ages of 18 and 98, of which 10% were over the age of 60, showed 78% Interim Clinical Efficacy. 100% efficacy was recorded […]
Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
by
A rare and critical type of blood clot called cerebral venous sinus thrombosis (CVST) has been detected in combination with low levels of blood platelets (thrombocytopenia) in six women between the ages of 18 and 48, 6 to 13 days after they received doses of the Johnson & Johnson (Janssen) vaccine in the U.S. More […]
All Californians 16+ Now Eligible for COVID-19 Vaccines
by
Following major milestones in its vaccination program, with almost half its population aged 16 and up and 73.9% of seniors over 65 have received one dose, all residents of the state of California ages 16 and above have become eligible for COVID-19 vaccinations as of April 15 th. This decision meets President Biden’s nationwide deadline […]
